Programmed Cell Death 2-Like (PDCD2L) Peptide
PDCD2L
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PDCD2L products
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDCD2L antibody (Catalog #: ARP50714_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
- Background
-
Over expression of PDCD2L attenutates TNF-alpha release in Daudi cells. PDCD2L over-expression restrained proliferation of HEK293T cells. DNA/flow cytometry analysis showed that the over-expression of PDCD2L severely delays cell cycle progression at S phase. These all suggest that PDCD2L might play a role in apoptosis.
Alias Symbols: MGC13096
Protein Size: 358 - Molecular Weight
- 39 kDa
- Gene ID
- 84306
- NCBI Accession
- NM_032346, NP_115722
- UniProt
- Q9BRP1
-
You are here:
